International Ophthalmic Industry Executive Paul Smith Joins TearLab


SAN DIEGO— TearLab Corporation (Nasdaq:TEAR) announced the appointment of Paul Smith to its senior management team in the newly created position of vice president, International. Smith's mandate will be the development and execution of a comprehensive international business strategy for TearLab, according to the company.

Smith brings a wealth of international ophthalmic sales and marketing, operations and general management experience to the company. He joins TearLab from his current position as global marketing manager within the Surgical Cataract Franchise at Alcon Laboratories Inc. In that role, he was responsible for portfolio management, strategy formulation and implementation for Alcon's largest device franchise, representing over $1 billion in annual revenue.

His 12 years of experience at Alcon includes previous positions involving surgical/instrumentation, pharmaceutical and consumer business unit operations and strategy management in global markets.

"Alcon is well-recognized as a leader in the ophthalmic space, both at home and abroad," said TearLab's CEO, Elias Vamvakas. "Paul's experience at Alcon brings an important depth of knowledge of the international ophthalmic device and pharmaceutical space to TearLab's management team, and we are very pleased to have attracted an executive of his caliber to this important new position."